Skip to main content

Table 7 Symptom scales in maintenance therapy arms 1–3, and arms 2+3 versus control arm 5

From: A new promising way of maintenance therapy in advanced ovarian cancer: a comparative clinical study

Characteristic

Arm 1

(n = 46)

Arm 2

(n = 76)

Arm 3

(n = 42)

Arms 2 + 3

(n = 118)

Arm 5

(n = 80)

At screening

 MS ± SD

19.68 ± 8.52

19.19 ± 8.90

18.19 ± 7.74

18.84 ± 8.49

19.71 ± 8.94

p*

0.9868

0.7207

0.3619

0.4953

 

After combined treatment

 MS ± SD

31.39 ± 8.20

31.25 ± 7.77

31.66 ± 5.57

31.39 ± 7.05

31.25 ± 6.58

p*

0.9135

0.9999

0.7376

0.8870

 

At the end of the study

 MS ± SD

34.59 ± 21.53

29.28 ± 20.33

30.01 ± 23.19

29.57 ± 21.34

34.83 ± 19.21

p*

0.9644

0.2494

0.3970

0.2588

 
  1. MS mean score, SD standard deviation
  2. *Student’s test was applied to determine the differences between arms 1–3 vs arm 5 and arms 2+3 vs arm 5